BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 24, 2011
View Archived Issues
Monoclonal antibody recognizes human embryonic stem cells with teratoma-forming potential
Read More
FDA provides draft guidelines on medical device approval and biomarker qualification
Read More
Omecamtiv mecarbil improves cardiac function in phase II study
Read More
Scientists isolate broadly neutralizing antibodies against HIV
Read More
New corticotropin-releasing factor CRF1 receptor antagonists disclosed
Read More
Swiss research team prepares novel chemokine CXCR7 receptor agonists
Read More
NovaDel signs agreement with Rechon Life Science for Zolpimist
Read More
FDA approves FISH-based in vitro diagnostic test for chronic lymphocytic leukemia
Read More
Allergan patents new cannabinoid CB2 receptor agonists
Read More
Novel epidermal growth factor receptor inhibitors synthesized by Chinese company
Read More
Chinese teams disclose new protein kinase inhibitors
Read More
Vertex presents novel protein kinase C inhibitors
Read More
Health Canada accepts NDS for lurasidone
Read More
Phase II trial of Adcetris in CD30-positive non-Hodgkin's lymphoma begins
Read More
Helsinn Therapeutics enrolls first patient in anamorelin phase III program
Read More
Mayo Clinic receives grant to investigate genetic risk of heart and blood vessel diseases
Read More
Thermo Fisher Scientific acquires Phadia
Read More
EP-217609 obtains European orphan drug status
Read More
Vernalis begins dosing in phase I trial of Parkinson's disease candidate
Read More
FDA sets PDUFA date for Amgen's sBLA for Xgeva
Read More
BiondVax Pharmaceuticals commences new phase II study of Multimeric-001 influenza vaccine
Read More
BMS submits applications in Japan for additional indications for two anticancer drugs
Read More
Recruitment begins in phase III Botox trial in patients with stroke
Read More